Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.

At this stage of life, it's vital to lift weights, avoid getting too thin, reduce alcohol and keep up to date with jabs ...

Builds on positive top-line data from first cohort demonstrating significant reduction in urinary incontinence episodes Paris, France, October 6, 2025 – EG 427, a biotechnology company leading the ...

Cervical epithelial cells are far from passive bystanders in the body's immune system. New research shows they actually play an active and highly coordinated role in detecting and fighting infections.

Urinary tract infections (UTIs) are one of the most common bacterial infections, especially among women. While an occasional ...

Pumpkin seed oil is linked to better hair growth, skin health, and heart and bladder function, and it may ease menopause ...

Antimicrobial resistance is outpacing advances in modern medicine, threatening the health of families worldwide,” warned Dr.

WHO warns of widespread resistance to common antibiotics worldwide: Geneva Tuesday, October 14, 2025, 12:00 Hrs [IST] One in six laboratory-confirmed bacterial infections causing ...

Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...

FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...

After completing his residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, Ladapo went to the NYU ...

Bristol Myers Squibb (NYSE: BMY) today announced the launch of its COBENFY Connections™ initiative in partnership with culinary expert, TV host and author Gail Simmons.* Launching on World Mental ...